Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 21, 2021, primarily to furnish a press release detailing their first-quarter 2021 financial results. The filing itself does not contain detailed financial statements but directs investors to the attached press release for operational and financial performance. The company is providing forward-looking statements subject to various risks and uncertainties, including the ongoing impact of the COVID-19 pandemic, healthcare cost trends, regulatory changes (particularly concerning the ACA), and competitive pressures.
Key Highlights
- 1Elevance Health (then Anthem) released its Q1 2021 financial results via a furnished press release on April 21, 2021.
- 2The 8-K filing serves as notification and provides access to the Q1 2021 earnings press release (Exhibit 99.1).
- 3The company highlighted forward-looking statements, cautioning investors about potential risks and uncertainties.
- 4Key risk factors mentioned include the impact of large-scale medical emergencies like COVID-19, healthcare cost trends, and regulatory environment changes, especially concerning the ACA.
- 5Competitive pressures and the ability to adapt to industry changes are also noted as significant factors.
- 6The company also referenced litigation, government investigations, and risks related to its pharmacy benefit management (PBM) business.
Frequently Asked Questions
The primary purpose of this 8-K filing is to formally furnish the press release containing Elevance Health's (then Anthem, Inc.) financial results for the first quarter ended March 31, 2021. It serves as an official notification and provides investors with access to this important information.
The detailed financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing. The 8-K itself does not contain the financial statements but refers investors to this exhibit.
Elevance Health highlighted several risks, including the impact of public health emergencies like COVID-19, fluctuations in healthcare costs and utilization, changes in federal and state regulations (particularly the ACA), competitive market dynamics, and potential litigation or government investigations.
Yes, the filing explicitly states that it contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which discuss future expectations and plans, are subject to risks and uncertainties that could cause actual results to differ materially from projections.